ASArchan Sil

Archan Sil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Archan Sil has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unearthing Hereditary Angioedema in India—Epidemiology From Chandigarh and Reasi, India

    by Ankur K. Jindal, Prabal Barman, Suprit Basu, Reva Tyagi, Archan Sil, Ridhima Aggarwal, Sanghamitra Macchua, Gopika Kalsotra, Pramod Kalsotra, Sendhil M. Kumaran, et al.

    Summary: The prevalence of HAE in Chandigarh and Reasi was 1/100,000 and 10/100,000 populations, respectively. Delay in diagnosis is less in regions where there is access to dedicated healthcare facilities and better awareness of HAE.


  • Open Access

    Successful coil occlusion of intracranial aneurysm in a child with STAT3 hyper IgE syndrome

    by Archan Sil, Chirag K. Ahuja, Pandiarajan Vignesh, Amit Rawat, Biman Saikia

    A novel heterozygous STAT3 variant (p.Phe710Ser) was identified in an adolescent with hyper IgE syndrome and an intracranial aneurysm. Successful nonsurgical coil occlusion underscores the importance of vascular screening and the feasibility of interventional radiology in HIES.

  • Early onset polyarthritis: an unusual presentation of MHC class II deficiency

    by Archan Sil, Abarna Thangaraj, Debasis Patro, Jigna N Bathia, Anand P Rao, Priyankar Pal, Pandiarajan Vignesh, Amit Rawat

    Archan Sil, Abarna Thangaraj, Debasis Patro, Jigna N Bathia, Anand P Rao, Priyankar Pal, Pandiarajan Vignesh, Amit Rawat; Early Onset Polyarthritis: An Unusual


  • Open Access

    Psychological Assessment and behavioral Interventions in a young girl with antineutrophil cytoplasmic antibody associated vasculitis

    by Rajni Sharma, Gummadi Anjani, Murugan Sudhakar, Ankur Jindal, Deepti Suri, Archan Sil, Ruchi Saka, Surjit Singh

    Antineutrophil cytoplasmic antibody (ANCA) vasculitis is a rare multisystem small vessel vasculitis in children. Apart from usual clinical management, psychosocial issues are also need to be addressed. We report a young girl with ANCA vasculitis and associated psychosocial stressors who responded to timely intervention through cognitive behavior therapy.

  • X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India

    by Ankur Kumar Jindal, Sanjib Mondal, Archan Sil, Amit Rawat, Sanchi Chawla, Rahul Tyagi, Murugan Sudhakar, Aaqib Zaffar Banday, Deepti Suri, Pandiarajan Vignesh, et al.

    Introduction: X-linked lymphoproliferative syndrome (XLP) is a rare primary immune deficiency. Two types of XLP have been described: XLP-1 and XLP-2. Methods: We found 7 patients with XLP (3 had XLP-1 and 4 had XLP-2) after reviewing the data from Pediatric Immunodeficiency Clinic from 1997 to 2021. Results: Mean age at diagnosis was 3.8 years, and mean delay in diagnosis was 2.6 years. Five patients had recurrent episodes of infections. Four patients developed at least one episode of hemophagocytic lymphohistiocytosis (HLH) (2 with XLP-1 and 2 with XLP-2). Of these, 2 had recurrent HLH (both with XLP-2). Epstein-Barr virus (EBV) infection was detected in 2 (1 with XLP-1 and 1 with XLP-2). Both these patients had HLH. One child with XLP-2 had inflammatory bowel disease. Hypogammaglobulinemia was seen in 3 (2 with XLP-1 and 1 with XLP-2). Genetic analysis showed previously reported variants in 5, while 2 had novel variants (one in exon 7 of XIAP gene [c.1370dup p.Asn457Lysfs Ter16] and other had splice site variant in intron 1 of SH2D1A gene [c.138-2_138-1insG]). Episodes of HLH were managed with intravenous immunoglobulin (IVIg), methylprednisolone, oral prednisolone, cyclosporine, and rituximab. Inflammatory bowel disease was managed using oral prednisolone and azathioprine. One patient underwent haploidentical hematopoietic stem cell transplantation. One child with XLP-2 and WAS died because of fulminant pneumonia. Discussion/Conclusions: XLP should be considered as a strong possibility in any patient with features of HLH, repeated infections with hypogammaglobulinemia, persistent EBV infection, and early-onset IBD.


  • Delay in diagnosis is the most important proximate reason for mortality in hereditary angio-oedema: our experience at Chandigarh, India

    by Ankur Kumar Jindal, Suprit Basu, Reva Tyagi, Prabal Barman, Archan Sil, Sanchi Chawla, Anit Kaur, Rahul Tyagi, Isheeta Jangra, Sanghamitra Machhua, et al.

    Background: Hereditary angio-oedema (HAE) is a rare autosomal dominant disorder characterized clinically by recurrent episodes of nonpruritic subcutaneous and/or submucosal oedema. Laryngeal oedema is the commonest cause of mortality in patients with HAE. Prior to the availability of first-line treatment options for the management of HAE, mortality was as high as 30%. Mortality has significantly declined in countries where first-line treatment options are available and patients can access these therapies. There is a paucity of literature on the outcomes of patients with HAE in developing countries where availability of and access to first-line treatment options are still a challenge. Objectives: To report our experience on mortality in patients with HAE and to report factors associated with the death of these patients. Methods: We carried out a record review of all patients diagnosed with HAE between January 1996 and August 2022. Families with HAE who had reported the death of at least one family member/relative from laryngeal oedema were studied in detail. Results: Of the 65 families (170 patients) registered in the clinic, 16 families reported the death of at least one family member/relative from laryngeal oedema (total of 36 deaths). Of these 16 families, 14 reported that 1 or more family members had experienced at least 1 attack of laryngeal oedema. One patient died during follow-up when she was taking long-term prophylaxis with stanozolol and tranexamic acid, while the remaining 35 patients were not diagnosed with HAE at the time of their death. At the time of death of all 36 patients, at least 1 other family member had symptoms suggestive of HAE, but the diagnosis was not established for the family. Conclusions: To our knowledge, this is the largest single-centre cohort of patients with HAE in India reporting mortality data and factors associated with death in these families. The delay in diagnosis is the most important reason for mortality.


  • Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India

    by Ankur Kumar Jindal, Archan Sil, Ridhima Aggarwal, Rahul Tyagi, Sanjib Mondal, Ankita Singh, Prabal Barman, Sanchi Chawla, Sathish Kumar Loganathan, Kirti Gupta, et al.

    DOCK8 deficiency is an autosomal recessive form of combined immunodeficiency characterized by increased predisposition to allergy, autoimmunity and malignancies. To analyze clinical, immunological, and molecular profiles of patients with DOCK8 deficiency. Clinic records of all patients attending the primary immunodeficiency clinic from 2018 to 2021 were reviewed. Six patients from five families were found to have DOCK8 deficiency. Median age at diagnosis was 7.5 years (range: 2–13 years), with a male–female ratio of 5:1. Recurrent eczematous skin lesions were the predominant cutaneous manifestation present in 83% (5/6) of the patients. Warts and molluscum contagiosum were evident in 33% (2/6) and 16% (1/6) of the patients, respectively. Two patients had recalcitrant prurigo nodularis lesions and two had epidermodysplasia verruciformis (EV)-like lesions. Food allergies and asthma were reported by one patient each. Recurrent sinopulmonary infections were detected in 83% (5/6) of the patients. Epstein-Barr virus (EBV)-driven non-Hodgkin lymphoma with liver metastases was the only case of malignancy in a 4-year-old boy. IgE was elevated in all patients. Lymphopenia and eosinophilia were observed in 3/6 patients (50%) and 5/6 patients (83.3%), respectively. Genetic analysis showed homozygous deletion mutations in 2 patients, compound heterozygous deletion mutations in 1, and homozygous nonsense mutations in 2. A novel pathogenic homozygous missense variant in the DOCK8 gene was identified in one patient. DOCK8 deficiency should be considered as a possibility in any patient with early onset eczema, cutaneous viral infections and increased predisposition to allergy, autoimmunity and malignancy.


  • Disseminated Mycobacterium fortuitum infection in a young girl with IFN‐γR1 defect masquerading as histiocytosis

    by Archan Sil, Suprit Basu, Jhumki Das, Sunil Sethi, Debajyoti Chatterjee, Pandiarajan Vignesh, Deepti Suri, Ankur Kumar Jindal


  • Tuberculosis and Bacillus Calmette-Guérin Disease in Patients with Chronic Granulomatous Disease: an Experience from a Tertiary Care Center in North India

    by Pandiarajan Vignesh, Archan Sil, Ridhima Aggarwal, Wrik Laha, Sanjib Mondal, Manpreet Dhaliwal, Saniya Sharma, Rakesh Kumar Pilania, Ankur Kumar Jindal, Deepti Suri, et al.

    Chronic granulomatous disease (CGD) is a phagocytic defect characterized by recurrent bacterial and fungal infections. We report clinical profile of patients with CGD and mycobacterial infections in a cohort from North India. A review of clinical and laboratory records was carried out for patients with CGD registered at our center between 1990 and 2021. Of the 99 patients with CGD, 22 had mycobacterial infections—Mycobacterium tuberculosis and M. bovis-BCG in 11 each. Among the children with M. bovis-BCG infection, 6 had localized and 5 had disseminated BCG disease. Median age at onset of symptoms and diagnosis of BCG disease was 5 months and 15 months, respectively. While disseminated forms of BCG were noted only in CYBB defect, none of the patients with NCF1 defect developed complications due to BCG vaccine. A recurring radiological feature was left axillary lymph node calcification, which was present in around 50% of CGD patients with BCG infections. Of 11 patients with tuberculosis, pulmonary, pleuro-pulmonary, abdominal, and disseminated forms were present in 6, 1, 2, and 2, respectively. Median age at onset of symptoms and diagnosis of tuberculosis was 129 months and 130 months, respectively. Molecular defects were identified in CYBB (5), NCF1 (4), and CYBA (1). Incidence of tuberculosis and BCG-related complications in patients with CGD is higher than the normal population. Screening for CGD is warranted in any patient with adverse reactions to BCG vaccination, calcification of left axillary lymph node, and persistent, recurrent or disseminated forms of tuberculosis.


  • Open Access

    Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring

    by Sanghamitra Machhua, Ankur Jindal, Suprit Basu, Ishita Jangra, Prabal Barman, Rahul Tyagi, Archan Sil, Reva Tyagi, Anit Kaur, Sanchi Chawla, et al.

    A document by Sanghamitra Machhua. Click on the document to view its contents.